Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3124435rdf:typepubmed:Citationlld:pubmed
pubmed-article:3124435lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3124435lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:3124435lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:3124435lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:3124435lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:3124435lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:3124435pubmed:dateCreated1988-3-8lld:pubmed
pubmed-article:3124435pubmed:abstractTextHuman myeloid leukemia cells have a growth advantage over normal cells because they do not differentiate into functional end-cells but remain in the proliferative pool. Several agents have been identified as inducers of differentiation of leukemia cells; among them are the retinoids, 1 alpha,25-dihydroxyvitamin D3 and human tumor necrosis factor alpha, which will be discussed in the following chapter.lld:pubmed
pubmed-article:3124435pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:languageenglld:pubmed
pubmed-article:3124435pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:citationSubsetIMlld:pubmed
pubmed-article:3124435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3124435pubmed:statusMEDLINElld:pubmed
pubmed-article:3124435pubmed:issn0001-5792lld:pubmed
pubmed-article:3124435pubmed:authorpubmed-author:KoefflerH PHPlld:pubmed
pubmed-article:3124435pubmed:authorpubmed-author:ToblerAAlld:pubmed
pubmed-article:3124435pubmed:issnTypePrintlld:pubmed
pubmed-article:3124435pubmed:volume78 Suppl 1lld:pubmed
pubmed-article:3124435pubmed:ownerNLMlld:pubmed
pubmed-article:3124435pubmed:authorsCompleteYlld:pubmed
pubmed-article:3124435pubmed:pagination127-35lld:pubmed
pubmed-article:3124435pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:meshHeadingpubmed-meshheading:3124435-...lld:pubmed
pubmed-article:3124435pubmed:year1987lld:pubmed
pubmed-article:3124435pubmed:articleTitleDifferentiation of human acute myelogenous leukemia cells: therapeutic possibilities.lld:pubmed
pubmed-article:3124435pubmed:affiliationUCLA School of Medicine.lld:pubmed
pubmed-article:3124435pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3124435pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3124435pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3124435pubmed:publicationTypeReviewlld:pubmed
pubmed-article:3124435pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed